6-(3-Methoxyphenyl)-N-(3,4,5-trimethoxyphenyl)thieno[3,2-d]-pyrimidin-4-amine

ID: ALA4520163

PubChem CID: 155542244

Max Phase: Preclinical

Molecular Formula: C22H21N3O4S

Molecular Weight: 423.49

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cccc(-c2cc3ncnc(Nc4cc(OC)c(OC)c(OC)c4)c3s2)c1

Standard InChI:  InChI=1S/C22H21N3O4S/c1-26-15-7-5-6-13(8-15)19-11-16-21(30-19)22(24-12-23-16)25-14-9-17(27-2)20(29-4)18(10-14)28-3/h5-12H,1-4H3,(H,23,24,25)

Standard InChI Key:  GFEZIYFTLOBGJY-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 30 33  0  0  0  0  0  0  0  0999 V2000
   31.1974  -18.5917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.9071  -18.1823    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.9043  -17.3596    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.1957  -16.9544    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.4894  -18.1827    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.4861  -17.3662    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.7085  -17.1170    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.2312  -17.7796    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.7139  -18.4381    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   31.1972  -19.4089    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.9049  -19.8177    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.9005  -20.6331    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.6073  -21.0418    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.3161  -20.6333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.3137  -19.8119    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.6063  -19.4069    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.6067  -21.8590    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   33.3141  -22.2681    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.0242  -21.0411    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.7315  -20.6318    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.0200  -19.4010    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.0173  -18.5838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.4186  -17.7836    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.0077  -17.0759    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.1913  -17.0789    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.7847  -17.7888    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.2006  -18.4972    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.0157  -18.4907    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.7801  -16.3727    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   25.9629  -16.3756    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  5  1  1  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  6  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9  5  1  0
  1 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
 13 17  1  0
 17 18  1  0
 14 19  1  0
 19 20  1  0
 15 21  1  0
 21 22  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 23  1  0
  8 23  1  0
 25 29  1  0
 29 30  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4520163

    ---

Associated Targets(Human)

RS4-11 (1012 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Jurkat (10389 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 423.49Molecular Weight (Monoisotopic): 423.1253AlogP: 5.14#Rotatable Bonds: 7
Polar Surface Area: 74.73Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 2.93CX LogP: 4.36CX LogD: 4.36
Aromatic Rings: 4Heavy Atoms: 30QED Weighted: 0.44Np Likeness Score: -1.06

References

1. Romagnoli R, Prencipe F, Oliva P, Baraldi S, Baraldi PG, Schiaffino Ortega S, Chayah M, Kimatrai Salvador M, Lopez-Cara LC, Brancale A, Ferla S, Hamel E, Ronca R, Bortolozzi R, Mariotto E, Mattiuzzo E, Viola G..  (2019)  Design, Synthesis, and Biological Evaluation of 6-Substituted Thieno[3,2- d]pyrimidine Analogues as Dual Epidermal Growth Factor Receptor Kinase and Microtubule Inhibitors.,  62  (3): [PMID:30633509] [10.1021/acs.jmedchem.8b01391]

Source